Vitamin K2 Reduces Recurrence of Liver Cancer
Sixty patients with hepatocellular carcinoma resulting from chronic hepatitis C, who were apparently free of cancer after radio frequency ablation therapy or surgery, were randomly assigned to receive 45 mg per day of vitamin K2 (menaquinone-4) or no vitamin K (control group).
These results indicate that supplementation with vitamin K2 significantly reduced the recurrence rate of hepatocellular carcinoma and non-significantly increased the survival rate in patients with a history of hepatocellular carcinoma, secondary to chronic hepatitis C.
Read details of this vitamin K2 liver cancer study.
0 Comments:
Post a Comment
<< Home